News and Trends 3 Apr 2020UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection of 15,000 potential coronavirus disease… April 3, 2020 - 4 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
Startup Scout 14 Feb 2020Novadiscovery Carries out Clinical Trials using AI and Simulations Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes and cut their running costs.… February 14, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2020French Partnership Deploys AI for Antibody Drug Discovery French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence.… February 13, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2020Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI for the treatment of autism… February 4, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2020AI-Designed Drug Enters Phase I to Treat OCD A drug designed by the UK firm Exscientia using AI-powered software has entered into a phase I clinical trial for… January 31, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 5 Nov 2019UK Scientists Speed up Brain Cancer Diagnosis with AI A technique combining a blood test with artificial intelligence (AI), developed by the UK company ClinSpec Diagnostics, could help to… November 5, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Oct 2019AI-Driven Antibiotic Susceptibility Test Launched in Austria Ares Genetics, an Austrian subsidiary of the German Curetis Group, has launched an early access program for its AI-driven antibiotic… October 28, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Startup Scout 25 Oct 2019This UK AI Tool Researches Diseases for Drug Discovery Companies The Manchester-based company Biorelate is developing artificial intelligence (AI) technology that can collect biological data from the internet and speed… October 25, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2019British AI Firm Gets €9M Boost to Develop Drug-Discovery Tech London-based LabGenius has secured €8.9M in Series A funding, which the company plans to use to scale up its AI-… October 24, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 23 Oct 2019Channeling the Power of AI into Personalizing Medicine Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to… October 23, 2019 - 7 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 16 Oct 2019UK Firm Raises €51M to Repurpose Drugs for Rare Diseases Using AI The Cambridge-based artificial intelligence company Healx has raised a Series B round of €50.8M to launch an AI tool that… October 16, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Sep 2019IBM’s Watson for Genomics Launches in First European Hospital The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence… September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2019ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment Two companies based in Lausanne, Switzerland -- ADC Therapeutics and the genomics company SOPHiA Genetics -- have signed a deal… August 6, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 17 Jun 2019Artificial Intelligence in Oncology: Fantasy or Reality? Artificial intelligence promises to use the power of data to solve some of the biggest problems of our time. But… June 17, 2019 - 6 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 May 2019Top 10 Biotechs in Lausanne The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may… May 8, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2019Swiss Multi-Cancer Diagnostic Test Approved in Europe A cancer test developed by the Swiss company SOPHiA GENETICS has been approved for diagnosing multiple types of solid tumors… April 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2019Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop treatments for tumors that don’t… March 27, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2019Celgene and Exscientia Sign the Largest Deal in AI for Drug Discovery In a deal with €22M paid upfront and undisclosed “substantial milestones and royalties,” Exscientia will use its artificial intelligence technology… March 21, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2019Artificial Intelligence Detects Juvenile Arthritis in the Blood Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with almost 90% accuracy and identify… March 13, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jan 2019AI Drug Discovery Company Raises €23M and Signs with Roche Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with Roche worth up to €60M.… January 7, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email